Cited by 212Diabetes Management and ResearchDiabetes Treatment and ManagementDiabetes Management and Education

Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM.

Open access
Fanelli, C., Pampanelli, S., Epifano, L., Rambotti, A. M., Di Vincenzo, A., Modarelli, F., Ciofetta, M., Lepore, M. +7 more·1994·Diabetologia

Abstract

Hypoglycaemia unawareness, is a major risk factor for severe hypoglycaemia and a contraindication to the therapeutic goal of near-normoglycaemia in IDDM. We tested two hypotheses, first, that hypoglycaemia unawareness is reversible as long as hypoglycaemia is meticulously prevented by careful intensive insulin therapy in patients with short and long IDDM duration, and that such a result can be maintained long-term. Second, that intensive insulin therapy which strictly prevents hypoglycaemia, can maintain long-term near-normoglycaemia. We studied 21 IDDM patients with hypoglycaemia unawareness and frequent mild/severe hypoglycaemia episodes while on "conventional" insulin therapy, and 20 nondiabetic control subjects. Neuroendocrine and symptom responses, and deterioration in cognitive function were assessed in a stepped hypoglycaemia clamp before, and again after 2 weeks, 3 months and 1 year of either intensive insulin therapy which meticulously prevented hypoglycaemia (based on physiologic insulin replacement and continuous education, experimental group, EXP, n = 16), or maintenance of the original "conventional" therapy (control group, CON, n = 5). At entry to the study, all 21 IDDM-patients had subnormal neuroendocrine and symptom responses, and less deterioration of cognitive function during hypoglycaemia. After intensive insulin therapy in EXP, the frequency of hypoglycaemia decreased from 0.5 +/- 0.05 to 0.045 +/- 0.02 episodes/patient-day; HbA1c increased from 5.83 +/- 0.18 to 6.94 +/- 0.13% (range in non-diabetic subjects 3.8-5.5%) over a 1-year period; all counterregulatory hormone and symptom responses to hypoglycaemia improved between 2 weeks and 3 months with the exception of glucagon which improved at 1 year; and cognitive function deteriorated further as early as 2 weeks (p < 0.05). The improvement in responses was maintained at 1 year. The improvement in plasma adrenaline and symptom responses inversely correlated with IDDM duration. In contrast, in CON, neither frequency of hypoglycaemia, nor neuroendocrine responses to hypoglycaemia improved. Thus, meticulous prevention of hypoglycaemia by intensive insulin therapy reverses hypoglycaemia unawareness even in patients with long-term IDDM, and is compatible with long-term near-normoglycaemia. Because carefully conducted intensive insulin therapy reduces, not increases the frequency of moderate/severe hypoglycaemia, intensive insulin therapy should be extended to the majority of IDDM patients in whom it is desirable to prevent/delay the onset/progression of microvascular complications.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/bf00399801

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • As little as 2-3 weeks of scrupulous avoidance of treatment-induced hypoglycemia reverses hypoglycemia unawareness and improves the reduced epinephrine component of defective glucose counterregulation in most affected patients with type 1 diabetes mellitus.

    “Perhaps the most compelling support for the clinical impact of HAAF in T1DM is the finding that as little as 2-3 wk of scrupulous avoidance of treatment-induced hypoglycemia reverses hypoglycemia unawareness, and improves the reduced epinephrine component of defective glucose counterregulation in most affected patients (102-105).”

    From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [103]

    The Experimental group results report improved symptom awareness and a higher average adrenaline (epinephrine) response after two weeks of meticulous hypoglycaemia prevention. The Discussion says adrenaline recovery was limited or absent in patients with diabetes lasting more than 15 years, so the paper does not establish improvement in that component in most affected patients generally. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • The return of hypoglycemic symptom awareness was associated with a modest increase (∼0.5%) in HbAlc values, but others have reported no loss of glycemic control.

    “The return of hypoglycemic symptom awareness was associated with a modest increase (∼0.5%) in HbAlc values (33), but others have reported no loss of glycemic control (32,34).”

    From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [34]

    The Results report that symptom awareness returned after prevention of hypoglycaemia, alongside an increase in HbA1c. But HbA1c rose from 5.83% to 6.94% at three months—about 1.1 percentage points, not the approximately 0.5 attributed to this paper. The statement about other reports is cited to different sources and is not assessed here. (LLM, conf=0.91)

    Experimental — accuracy not yet measured
  • Merely directing people with type 1 diabetes to allow their HbA1c to increase is not expected to alter glycaemic thresholds or the associated burden of hypoglycaemia unless the rate of hypoglycaemia drops considerably.

    “Our data underscore, however, that merely directing people with type 1 diabetes to allow their HbA1c to increase is not expected to alter glycaemic thresholds or the associated burden of hypoglycaemia unless the rate of hypoglycaemia drops considerably [6, 32, 60].”

    From Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review (2022) · cites this paper as [32]

    The Results (page not provided) report that meticulous prevention reduced hypoglycaemia about tenfold, and the Experimental group section reports normalized glycaemic thresholds after two weeks. The paper supports the importance of reducing hypoglycaemia, but it did not test whether merely allowing HbA1c to rise, without reducing episodes, leaves thresholds or hypoglycaemia burden unchanged. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Strict avoidance of hypoglycemia for a period of 2 days to 3 months is associated with improvement in recognition of severe hypoglycemia, counterregulatory hormone responses, or both.

    “Strict avoidance of hypoglycemia for a period of 2 days to 3 months has been associated with improvement in the recognition of severe hypoglycemia, the counterregulatory hormone responses or both (32)(33)(34)(35)(36)(37)(38)(39).”

    From Hypoglycemia (2018) · cites this paper as [35]

    The Abstract and Experimental group results report improved counterregulatory hormone and symptom responses after meticulous prevention of hypoglycaemia, beginning at 2 weeks and continuing through 3 months. This paper does not report improvement after 2 days or directly measure recognition of severe hypoglycaemic episodes; the Results say no severe episodes occurred during follow-up. Page numbers are unavailable in our copy. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • A 2- to 3-week period of scrupulous avoidance of hypoglycemia can be expected to restore awareness in patients with a history of hypoglycemia unawareness.

    “Given a history of hypoglycemia unawareness, a 2-to 3-wk period of scrupulous avoidance of hypoglycemia is advisable because that can be expected to restore awareness (102-105).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 51 · Cited by 212

Research works printed but not linked: 3

  1. [3]3. Mokan M, Mitrakou A, Veneman T et al. (in press) Hypo- glycemia unawareness in insulin-dependent diabetes melli- tus. Diabetes Care (in press)
  2. [34]34. Boyle PJ, Nagy R, O'Connor AM et al. (in press) Adapta- tion in brain glucose uptake following recurrent hypoglyce- mia. Proc Natl Acad Sci USA (in press)
  3. [44]44. Dagogo-Jack S, Rattarasarn C, Cryer P Reversal of hypo- glycemia unawareness, but not glucose counterregulation, in insulin dependent diabetes mellitus. Diabetes (in press)

Authors
Fanelli, C., Pampanelli, S., Epifano, L., Rambotti, A. M., Di Vincenzo, A., Modarelli, F., Ciofetta, M., Lepore, M., Annibale, B., Torlone, E., Perriello, G., De Feo, P., Santeusanio, F., Brunetti, P., & Bolli, G. B.
Affiliations
  • University of Perugia (IT)
  • Sapienza University of Rome (IT)
Venue
Diabetologia
Published
1994-12
Volume
37
Issue
12
Pages
1265-1276
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2059292880
Cited by
212
References
51
Citations by year
2026: 1 · 2025: 3 · 2024: 5 · 2023: 2 · 2022: 3 · 2021: 1 · 2020: 4 · 2019: 4 · 2018: 9 · 2017: 6 · 2016: 5 · 2015: 12 · 2014: 7 · 2013: 15 · 2012: 6
FWCI
3.52
Type
journal article
Language
en
Open access
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
hypoglycemia unawareness, intensive insulin therapy, type 1 diabetes, hypoglycemia, epinephrine, glucagon, hypoglycaemic symptoms, cognitive function, HbA1c, diabetes duration, hypoglycemia prevention, long-term recovery
MeSH terms
Adult, Awareness, Blood Glucose, Cognition, Diabetes Mellitus, Type 1, Epinephrine, Female, Glucagon, Glycated Hemoglobin, Humans, Hydrocortisone, Hypoglycemia, Insulin, Male, Norepinephrine, Pancreatic Polypeptide, Reference Values, Growth Hormone, Time Factors, Glucose Clamp Technique, Body Mass Index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review